ST Pharm Co.Ltd - Asset Resilience Ratio

Latest as of December 2025: 7.72%

ST Pharm Co.Ltd (237690) has an Asset Resilience Ratio of 7.72% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does ST Pharm Co.Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

₩60.44 Billion

≈ $40.96 Million USD Cash + Short-term Investments

Total Assets

₩782.57 Billion

≈ $530.33 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how ST Pharm Co.Ltd's Asset Resilience Ratio has changed over time. See shareholders equity of ST Pharm Co.Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down ST Pharm Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ST Pharm Co.Ltd (237690) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩60.44 Billion	7.72%
Total Liquid Assets	₩60.44 Billion	7.72%

Asset Resilience Insights

Limited Liquidity: ST Pharm Co.Ltd maintains only 7.72% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

ST Pharm Co.Ltd Industry Peers by Asset Resilience Ratio

Compare ST Pharm Co.Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Theragen Etex Co.Ltd KQ:066700	Pharmaceuticals	1.52%
Sam Chun Dang Pharm. Co. Ltd KQ:000250	Pharmaceuticals	4.82%
Oscotec Inc KQ:039200	Pharmaceuticals	61.00%
Caregen Co.Ltd KQ:214370	Pharmaceuticals	4.58%
NatureCell Co.Ltd KQ:007390	Pharmaceuticals	0.00%
Mezzion Pharma Co.Ltd KQ:140410	Pharmaceuticals	13.09%
Huons Global Co. Ltd KQ:084110	Pharmaceuticals	5.46%
Kolon Life Science Inc KQ:102940	Pharmaceuticals	1.22%

Annual Asset Resilience Ratio for ST Pharm Co.Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for ST Pharm Co.Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	7.72%	₩60.44 Billion ≈ $40.96 Million	₩782.57 Billion ≈ $530.33 Million	-0.24pp
2024-12-31	7.97%	₩57.52 Billion ≈ $38.98 Million	₩721.88 Billion ≈ $489.20 Million	+2.05pp
2023-12-31	5.92%	₩40.00 Billion ≈ $27.11 Million	₩675.44 Billion ≈ $457.73 Million	+5.92pp
2022-12-31	0.00%	₩10.00 ≈ $0.01	₩570.65 Billion ≈ $386.72 Million	-13.21pp
2021-12-31	13.21%	₩65.87 Billion ≈ $44.64 Million	₩498.57 Billion ≈ $337.87 Million	-11.64pp
2020-12-31	24.85%	₩110.72 Billion ≈ $75.03 Million	₩445.57 Billion ≈ $301.96 Million	+13.64pp
2019-12-31	11.21%	₩38.24 Billion ≈ $25.92 Million	₩341.08 Billion ≈ $231.15 Million	-19.96pp
2018-12-31	31.17%	₩107.71 Billion ≈ $72.99 Million	₩345.51 Billion ≈ $234.14 Million	-3.50pp
2017-12-31	34.68%	₩132.30 Billion ≈ $89.66 Million	₩381.50 Billion ≈ $258.54 Million	+3.36pp
2016-12-31	31.32%	₩115.20 Billion ≈ $78.07 Million	₩367.78 Billion ≈ $249.24 Million	--

pp = percentage points

About ST Pharm Co.Ltd

KQ:237690 Korea Pharmaceuticals

Market Cap

$1.93 Billion

₩2.85 Trillion KRW

Market Cap Rank

#6414 Global

#168 in Korea

Share Price

₩152500.00

Change (1 day)

-6.67%

52-Week Range

₩71600.00 - ₩168700.00

All Time High

₩168700.00